Tumor Markers: US, Europe, Japan -- Emerging Opportunities and Business Expansion Strategies for Suppliers

NEW YORK, Aug. 10, 2011 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Tumor Markers: US, Europe, Japan--Emerging Opportunities and Business Expansion Strategies for Suppliers

http://www.reportlinker.com/p0558478/Tumor-Markers-US-Europe-Japan--Emerging-Opportunities-and-Business-Expansion-Strategies-for-Suppliers.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=In_Vitro_Diagnostic

Highlights

- Identifies and evaluates major business opportunities emerging in the tumor marker market during the next ten years

- Examines trends in the U.S., Europe and Japan

- Reviews current and emerging tumor markers

- Analyzes applications of emerging diagnostic technologies

- Forecasts sales of major tumor markers by country and market segment

- Profiles leading market players and potential entrants

- Suggests alternative business expansion strategies for suppliers.

Rationale

The cancer diagnostics market is on the verge of explosion, as the researchers approach major technological breakthroughs in tumor diagnosis and therapy, discover new specific antigens, and unlock the mystery of the genetic basis of the disease. During the next ten years, the worldwide cancer diagnostics market is promising to be an exciting, dynamic and rapidly expanding field. Anticipated technological breakthroughs will create numerous opportunities for determining genetic predisposition, detecting specific tumors, and monitoring biological response to cancer therapy. The rise in geriatric population will further compound the growing demand for malignancy assays and the rapid market expansion worldwide.

Geographic Coverage

- France

- Germany

- Italy

- Japan

- Spain

- UK

- USA

Market Segmentation Analysis

- Sales and market shares of major suppliers, by individual tumor marker and country.

- Ten-year test volume and sales forecasts for major tumor markers by country and market segment, including:

- Hospitals

- Commercial/Private Laboratories

- Physician Offices/Group Practices

- Cancer Clinics

- Ambulatory Care Centers

- Comprehensive market segmentation analysis, including review of the market dynamics, structure, size, growth and major suppliers by country.

- Cancer statistics, etiology and recent developments in the U.S., Japan and five major European countries.

Current and Emerging Products

- Review of over 200 current and emerging tumor markers, including:

- Biochemical Markers

- Oncogenes

- Growth Factors

- Hormones

- Colony Stimulating Factors

- Lymphokines

- Immunohistochemical Stains, and others.

- Analysis of major immunoassay analyzers used for tumor marker testing, including their operating characteristics, features and selling prices.

Technology Review

- Assessment of monoclonal antibodies, immunoassays, DNA probes, biochips/microarrays, chromosome analysis, IT, artificial intelligence, flow cytometry, biosensors, and their potential applications for tumor marker testing.

- Review of competing/complementing technologies, including CT, MRI, NMR, PET and photonics spectroscopy.

- Extensive listings of over 500 companies, universities and research centers developing new tumor markers and detection technologies.

Competitive Assessments

- Extensive strategic assessments of major suppliers and start-up firms developing innovative

technologies and products, including their sales, product portfolios, marketing tactics, collaborative arrangements and new products in R&D.

Worldwide Market Overview

- Estimated universe of laboratories performing tumor marker testing by country.

- Ten-year test volume and sales projections by country.

Business Opportunities and Strategic Recommendations

- Specific new product development opportunities with potentially significant market appeal during the next ten years.

- Design criteria for new products.

- Alternative market penetration strategies.

- Potential market entry barriers and risks.

Methodology

This report is based on interviews with clinical pathologists, laboratory directors, executives from leading diagnostic companies and start-up firms developing innovative products, university scientists, as well as experts from industry associations, venture capital firms and the investment banking community in the U.S., five major European countries and Japan.

The market projections are also based on questionnaire responses received from hospitals, commercial/private laboratories, physician offices/group practices, cancer clinics and ambulatory care centers in seven countries.

In addition to primary sources of information, a comprehensive review of the most recent technical and business publications, manufacturer product literature, patents, trade association surveys, government studies, marketing and technical meeting presentations, industry analyst reports, and VPG's proprietary data files was conducted.

Contains 1,200 pages and 450 tables

Table of Contents

Introduction

Worldwide Market and Technology Overview

A. Cancer Statistics and Etiology

1. Bladder

2. Breast

3. Cervical

4. Colon and Rectum

5. Endometrial

6. Esophagus

7. Head and Neck

8. Leukemia

9. Lung

10. Lymphoma

11. Oral

12. Ovarian

13. Prostate

14. Renal Cell Carcinoma

15. Skin

16. Stomach

17. Uterine

B. Major Current And Emerging Tumor Marker

1. Introduction

2. Tumor Marker Classification

3. ACTH

4. Alpha-Fetoprotein (AFP)

5. Beta-2 Microglobulin

6. CA 15-3/27.29

7. CA 19-9

8. CA-125

9. Calcitonin

10. Carcinoembrionic Antigen (CEA)

11. Estrogen and Progesterone Receptors

12. Ferritin

13. Gastrin

14. Human Chorionic Gonadotropin (HCG)

15. Insulin

16. Lymphocytes CD4/CD8

17. NSE

18. Occult Blood

19. PAP Smear/HPV

20. Prostatic Acid Phosphatase (PAP)

21. Prostate-Specific Antigen (PSA)

22. Squamous Cell Carcinoma Antigen (SCC)

23. TdT

24. Thyroglobulin

25. Tissue Polypeptide Antigen (TPA)

26. Biochemical Tumor Markers

- ADA

- B-Protein

- PNP

- 5'-Nucleotidase

27. Oncogenes

- Abl/abl-bcr

- AIB1

- APC

- BTA 26

- BCL-2

- BCR-ABL

- B-raf

- BRCA

- CD44

- CDK

- C-abl

- C-fos

- C-myb

- C-myc

- CYCD1

- CYP-17

- DPC

- E-myc

- Erb-B

- HER-2/neu

- HPC1

- HSTF

- L-myc

- MET

- MSH

- NEU

- N-myc

- N-telopeptide

- PCA3

- PIK3CA

- PTI-1

- P10

- P40

- P51

* P53

* Ras

* Reg

* RET

* sFas

* Sis

- Src

28. Polypeptide Growth Factors

* Basic Fibroblast Growth Factor

* Beta-TGF

- Cachectin (TNT)

* Calmodulin

* ECFR

* Nerve Growth Factor (NGF)

* Epidermal Growth Factor (EGF)

* Ornithine Decarboxylase

* Transferrin

* Transforming Growth Factor-Alpha

29. Ectopic Hormones

30. Colony Stimulating Factors

31. Lymphokines

* Alpha-Interferon

* B Cell Growth Factors

* B Cell Growth Factor (BCGF)

* Gamma-Interferon

* Interleukin-1 (IL-1)

* Macrophage Activating Factor

32. Immunohistochemical Stains

33. Emerging Tumor Markers

* N-Acetylglucosamine

* Actin

* Alpha-Actin

* Angiogenin

* Angiostatin

* Antineuronal Antibodies

- 7B2

* B72.3

- B-Protein

* Bax

- BCD-F9

* BLCA-4

- Blood Group Antigens A,B,H

* BTA

- CA 50

* CA 72-4/TAG-72

- CA 195

* CA-242

- CA-549

* Cadherin

- CAM 26

* CAR-3

- CD105

* Cathepsin-D

- Chromogranin A and B

* Cluster 1 Antigen

- Cluster-5/5A Antigen

* COX Antigen

- CTA

* CU18

- Cyclin

* DR-70

- DU-PAN-2

* Endometrial Bleeding Associated Factor

- Endostatin

* Epithelial Membrane Antigen

- FDP

* Feulgen Hydrolysis

- Fibronectin

* FSH

- (1->3)-L-fucosyltransferase

* Gastrin-Releasing Peptide (GRP)

- GDCFP-15

* Glucagon

- Glycoamines

* H23

- HAAH

* hk3

- HPA

* HSP27

- Human Carcinoma Antigen

* ICAM

- Intermediate Filaments

- Cytokeratins/CK18/Cyfra 21-1

- Desmin

- Gliofibrillary Acid Protein

- Neurofilaments

- Vimentin

* KA 93

- Kallikrein

- Kinases

* KP16D3

- LAI

* Leukocyte Common Antigen

- Lewis Antigens

* Lysophosphatidic Acid (LPA)

- Ma 695/Ma 552

* MABDF3

- MAG

* ME1

- Minactivin

* MN/CA9

- MSA

* Mucin Cancer Antigen (MCA)

- Multiple Tumor Suppressor 1

* Myosin

- NEA-130

* NMP22

- Nucleolar

- OA-519

* Opiod Peptides

- P-glycoprotein

* Pancreatic Oncofetal Antigen (POA)

- Parathyrcoid Hormone

* Placental Lactogen

- PR92

* Proliferative Index, Ki-67

- Px

* RB Inactivation/Deletion

- Ret

* S-100 Protein

- SCCL 175

* Selectin

- Serotonin

* Sialic Acid

- Sialyl SSEA-1/SLX

* SN10

- Somatostatin

* TA-90

- TABA

* Tachykinin

- TAG 12

* TPS

- Troponin

* Tubulin

- VCAM

* VEGF

- Villen

- White Blood Cell Markers

C. Instrumentation Review And Market Needs

1. Abbott AxSYM

2. Abbott IMx

3. Anagen AN2000/AuraFlex

4. Beckman Coulter Access

5. BioChem Pharma SR1

6. bioMerieux Vidas Series

7. Biotrol Systems 7000

8. J&J Diagnostics/Amersham Amerlite

9. J&J Diagnostics Vitros ECI

10. Olympus PK Series

11. Roche Cobas Core

12. Roche Elecsys

13. Roche ES 22

14. Roche ES 33

15. Roche ES 300/300 AL

16. Siemens ACS: 180

17. Siemens ACS: Centaur

18. Siemens ELISA Processor II/III

19. Siemens Immuno 1

20. Siemens/Opus/Plus/Magnum

21. Siemens Stratus

22. Tosoh AIA Series

23. Wallac/Pharmacia Delfia

D. Current and Emerging Technologies

1. Monoclonal and Polyclonal Antibodies

2. Immunoassays

a. Technological Principle

b. Radioimmunoassay (RIA)

c. Enzyme Immunoassays (EIA)

- Overview

- ELISA

- Immunofiltration

- Particle-Membrane Capture Immunoassay

- Enzyme Amplification

d. Fluorescent Immunoassays

e. Luminescence

- Chemiluminescence

- Bioluminescence

3. Molecular Diagnostics

a. Technology Overview

b. Amplification Methods

- PCR

- DAP-PCR

- Immuno-PCR

- QC-PCR

- CAR

- DNA

- HPA

- LCR

- NASBA

- QBR

- SDA

- 3 SR, and others

4. Biochips/Microarrays

5. Chromosome Analysis

a. Chronic Myelogenous Leukemia (CML)

b. Acute Myeloid Leukemia (AML)

c. Acute Lymphoblastic Leukemia (ALL)

d. Malignant Lymphomas

Lymphoid Malignancies

e. Chronic Lymphocytic Leukemia (CLL)

f. Solid Cancers

g. Chromosomal Translocation and Oncogenes

6. Microcomputers and Automation

7. Artificial Intelligence

8. Flow Cytometry

9. Biosensors

E. Competing/Complementing Technologies

1. CT

2. MRI

3. NMR

4. PET

5.Photonics Spectroscopy

F. Business Environment

1. Worldwide Market Structure

2. Worldwide Market Size and Growth

G. Personal Testing

France

A. Executive Summary

B. Business Environment

C. Market Structure

D. Market Size, Growth and Major Suppliers

Germany

A. Executive Summary

B. Business Environment

C. Market Structure

D. Market Size, Growth and Major Suppliers

Italy

A. Executive Summary

B. Business Environment

C. Market Structure

D. Market Size, Growth and Major Suppliers

Japan

A. Executive Summary

B. Business Environment

C. Market Structure

D. Market Size, Growth and Major Suppliers

Spain

A. Executive Summary

B. Business Environment

C. Market Structure

D. Market Size, Growth and Major Suppliers

U.K.

A. Executive Summary

B. Business Environment

C. Market Structure

D. Market Size, Growth and Major Suppliers

U.S.A.

A. Executive Summary

B. Business Environment

1. Health Care Expenditures

2. Cost Consciousness

3. Reimbursement

4. Industry Consolidation

5. Managed Care

a. HMO

b. PPO

6. Hospitals

7. Admissions

8. Length of Stay

9. Industry Diversification

10. Physician Demographics

11. Population Aging

a. Chronic Illness

b. Disease Incidence

c. Susceptibility to Iatrogenesis

d. Multiple Illness Cases

12. Laboratory Regulations

13. FDA Reform

C. Market Structure

1. Centralized Testing

a. Hospitals

b. Commercial/Private Laboratories

2. POT/Decentralized Testing

a. Physician Offices/Group Practices

b. Cancer Clinics

c. Other Decentralized Testing Locations

D. Market Size, Growth and Major Suppliers Sales,

Instrument Placements and Market Shares

Major Product Development Opportunities

A. Reagent Kits and Test Systems/Panels

B. Instrumentation

C. Computers, Software and Automation

D. Auxiliary Products

Design Criteria for Decentralized Testing Products

Alternative Market Penetration Strategies

A. Internal Development

B. Collaborative Arrangements

C. University Contracts

D. Distribution Strategies

1. Marketing Approaches

2. Product Complexity

3. Customer Preference

4. Established Suppliers

5. Emerging Suppliers

6. Major Types of Distributors

7. Market Segmentation Factor

Potential Market Entry Barriers and Risks

A. Market Maturity

B. Cost Containment

C. Competition

D. Technological Edge and Limitations

E. Patent Protection

F. Regulatory Constraints

G. Decentralized Testing Market Challenges

Competitive Profiles

- Abbott

- AdnaGen

- Ambrilia Biopharma

- AMDL

- Beckman Coulter

- Becton Dickinson

- Biomedical Diagnostics

- bioMerieux

- Bio-Rad

- CanAG Diagnostics

- CeMines

- Cepheid

- Correlogic Systems

- Dako

- Decode

- Diadexus

- Diagnocure

- Diasorin

- Eiken Chemical

- Enterix

- Enzo Biochem

- Epigenomics

- Exact Sciences

- Fujirebio

- Gen-Probe

- Guided Therapeutics

- Hologic

- Ipsogen

- J&J Diagnostics

- Kreatech

- Kyowa Medex

- Mackay Life Sciences

- Matritech

- Myriad Genetics

- OncoLab

- Panacea Pharmaceuticals

- Polartechnics

- Polymedco

- PreMD

- Qiagen

- Radient Pharmaceuticals

- Roche

- Scienion

- Sequenom

- Siemens Healthcare

- Takara Bio

- Targeted Diagnostics & Therapeutics

- Tosoh

- Veridex

- Wako Pure Chemicals

- Wallac

- Zila

Appendixes

Appendix I: Major Companies Developing or

Marketing Tumor Marker Reagents

and Instruments

Appendix II: Major Universities and Research

Centers Developing Tumor Marker

Detection

Technologies and Applications

Appendix III: Assumed Currency Exchange Rates

List of Tables

Tumor Marker Classification

Major Companies Developing or Marketing

ACTH Tests

Major Companies Developing or Marketing

AFP Tests

Major Companies Developing or Marketing

Beta-2 Microglobulin Tests

Major Companies Developing or Marketing

CA 15-3/27.29 Tests

Major Companies Developing or Marketing

CA 19-9 Tests

Major Companies Developing or Marketing

CA 125 Tests

Major Companies Developing or Marketing

Calcitonin Tests

Major Companies Developing or Marketing

CEA Tests

Major Companies Developing or Marketing

Estrogen Receptor Tests

Major Companies Developing or Marketing

Progesterone Receptor Tests

Major Companies Developing or Marketing

Ferritin Tests

Major Companies Developing or Marketing

Gastrin Tests

List of Tables (continued)

Major Companies Developing or Marketing

HCG Tests

Major Companies Developing or Marketing

Insulin Tests

Major Companies Developing or Marketing

NSE Tests

Major Companies Developing or Marketing

Occult Blood Tests

Major Companies Developing or Marketing

PAP Smear/HPV Tests

Major Companies Developing or Marketing

PAP Tests

Major Companies Developing or Marketing

PSA Tests

Major Companies Developing or Marketing

Lymphocyte Subclassification Tests

Biochemical Markers Potential Applications

In Cancer Diagnosis

Oncogenes Potential Applications

In Cancer Diagnosis

Major Companies Developing or Marketing

Oncogene Tests

Growth Factors Potential Applications

In Cancer Diagnosis

Colony Stimulating Factors Potential

Applications in Cancer Diagnosis

Lymphokines Potential Applications

In Cancer Diagnosis

List of Tables (continued)

Immunohistochemical Stains Potential

Applications in Cancer Diagnosis

Executive Summary Table: France, Total Tumor

Marker Test Volume and Sales Forecast by Market

Segment

France, Estimated Cancer Death Rates

Per 100,000 Population

France, Laboratories Performing Tumor

Marker Tests by Market Segment

France, Hospital Laboratories Performing

Tumor Marker Tests by Bed Size

France, Commercial/Private Laboratories

Performing Tumor Markers by Annual

Test Volume

France, Total Tumor Marker Volume

Forecast by Market Segment

France, All Market Segments Major Tumor

Marker Test Volume Forecast

France, Hospital Laboratories Major Tumor

Marker Test Volume Forecast by Test

France, Commercial/Private Laboratories

Major Tumor Marker Test Volume Forecast

France, Total Tumor Marker Sales Forecast

By Market Segment

France, All Market Segments Major Tumor

Marker Sales Forecast by Test

France, Hospital Laboratories Major Tumor

Marker Sales Forecast by Test

List of Tables (continued)

France, Commercial/Private Laboratories

Tumor Marker Market Forecast by Test

France, ACTH Test Volume and Diagnostics Sales

Forecast by Market Segment

France, AFP Test Volume and Diagnostics Sales

Forecast by Market Segment

France, Beta-2 Microglobulin Test Volume and

Diagnostics Sales Forecast by Market Segment

France, CA 15-3/27.29 Test Volume and

Diagnostics Sales Forecast by Market

Segment

France, CA 19-9 Test Volume and Diagnostics

Sales Forecast by Market

France, CA-125 Test Volume and Diagnostics

Sales Forecast by Market Segment

France, Calcitonin Test Volume and Diagnostics

Sales Forecast by Market Segment

France, Cathepsin Test Volume and Diagnostics

Sales Forecast by Market Segment

France, CEA Test Volume and Diagnostics Sales

Forecast by Market Segment

France, Colon-Specific Antigen Test Volume

And Diagnostics Sales Forecast by Market

Segment

France, Cytokeratins Test Volume and

Diagnostics Sales Forecast by Market Segment

List of Tables (continued)

France, Estrogen Receptor Test Volume and

Diagnostics Sales Forecast by Market Segment

France, Ferritin Test Volume and

Diagnostics Sales Forecast by Market

Segment

France, Gastrin Test Volume and Diagnostics

Sales Forecast by Market Segment

France, HCG Test Volume and Diagnostics Sales

Forecast by Market Segment

France, Insulin Test Volume and Diagnostics

Sales Forecast by Market Segment

France, Interferons Test Volume and

Diagnostics Sales Forecast by Market

Segment

France, Interleukins Test Volume and

Diagnostics Sales Forecast by Market

Segment

France, Lymphocyte Subtyping Test Volume

And Diagnostics Sales Forecast by Market

Segment

France, NSE Test Volume and Diagnostics

Sales Forecast by Market Segment

France, Nucleolar Test Volume and Diagnostics

Sales Forecast by Market Segment

France, Occult Blood Test Volume and

Diagnostics Sales Forecast by Market

Segment

List of Tables (continued)

France, Oncogenes Test Volume and

Diagnostics Sales Forecast by Market

Segment

France, Pancreatic Oncofetal Antigen

Test Volume and Diagnostics Sales

Forecast by Market Segment

France, PAP Smear Test Volume and

Diagnostics Sales Forecast by Market

Segment

France, Parathyroid Hormone Test Volume and

Diagnostics Sales Forecast by Market

Segment

France, Progesterone Receptor Test Volume

And Diagnostics Sales Forecast by Market

Segment

France, PAP Test Volume and Diagnostics Sales

Forecast by Market Segment

France, PSA Test Volume and Diagnostics Sales

Forecast by Market Segment

France, S-100 Protein Test Volume and Sales

Diagnostics Sales Forecast by Market

Segment

France, Serotonin Test Volume and

Diagnostics Sales Forecast by Market

Segment

France, Sialic Acid Test Volume and

Diagnostics Sales Forecast by Market

Segment

List of Tables (continued)

France, Squamous Cell Carcinoma Antigen

Test Volume and Diagnostics Sales

Forecast by Market Segment

France, TDT Test Volume and Diagnostics Sales

Forecast by Market Segment

France, Thymidine Kinase Test Volume

And Diagnostics Sales Forecast by

Market Segment

France, Thyroglobulin Test Volume and

Diagnostics Sales Forecast by Market

Segment

France, TPA Test Volume and Diagnostics Sales

Forecast by Market Segment

France, Total Tumor Marker Sales

By Major Suppliers

France, AFP Testing Market Diagnostics

Sales by Major Supplier

France, CA 15-3 Testing Market Diagnostics

Sales by Major Supplier

France, CA 19-9 Testing Market Diagnostics

Sales by Major Supplier

France, CA 125 Testing Market Diagnostics

Sales by Major Supplier

France, CEA Testing Market Diagnostics

Sales by Major Supplier

France, NSE Testing Market Diagnostics

Sales by Major Supplier

List of Tables (continued)

France, PAP Testing Market Diagnostics

Sales by Major Supplier

France, PSA Testing Market Diagnostics

Sales by Major Supplier

France, Tumor Marker Testing

Instrumentation Major Systems

Estimated Placements and Installed

Base by Supplier and Model

Executive Summary Table: Germany, Total

Tumor Marker Test Volume and Sales Forecast

By Market Segment

Germany, Estimated Cancer Death Rates

Per 100,000 Population

Germany, Laboratories Performing Tumor

Marker Tests by Market Segment

Germany, Hospital Laboratories Performing

Tumor Marker Tests by Bed Size

Germany, Commercial/Private Laboratories

Performing Tumor Marker Tests by Annual

Volume

Germany, Total Tumor Marker Test Volume

Forecast by Market Segment

Germany, All Market Segments, Major Tumor

Marker Test Volume Forecast

Germany, Hospital Laboratories, Major

Tumor Marker Test Volume Forecast by

Assay

List of Tables (continued)

Germany, Commercial/Private Laboratories

Major Tumor Marker Test Volume

Forecast

Germany, Physician Offices/Group

Practices Major Tumor Marker

Test Volume Forecast

Germany, Total Tumor Marker Sales

Forecast by Market Segment

Germany, All Market Segments Major Tumor

Marker Sales Forecast by Assay

Germany, Hospital Laboratories, Major Tumor

Marker Sales Forecast by Test

Germany, Commercial/Private Laboratories

Major Tumor Marker Sales Forecast by Test

Germany, Physician Offices/Group Practices

Major Tumor Marker Sales Forecast by Test

Germany, ACTH Test Volume and Diagnostics

Sales Forecast by Market Segment

Germany, AFP Test Volume and Diagnostics

Sales Forecast by Market Segment

Germany, Beta-2 Microglobulin Test Volume

And Diagnostics Sales Forecast by Market

Segment

Germany, CA-15-3/27.29 Test Volume and

Diagnostics Sales Forecast by Market Segment

Germany, CA-19 Test Volume and Diagnostics

Sales Forecast by Market Segment

List of Tables (continued)

Germany, CA 125 Test Volume and Diagnostics

Sales Forecast by Market Segment

Germany, Calcitonin Test Volume and

Diagnostic Sales Forecast by Market

Segment

Germany, Cathepsin Test Volume and Diagnostics

Sales Forecast by Market Segment

Germany, CEA Test Volume and Diagnostics Sales

Forecast by Market Segment

Germany, Colon-Specific Antigen Test Volume

And Diagnostics Sales Forecast by Market

Segment

Germany, Cytokeratins Test Volume and

Diagnostics Sales Forecast by Market

Segment

Germany, Estrogen Receptor Test Volume and

Diagnostics Sales Forecast by Market

Segment

Germany, Ferritin Test Volume and Diagnostics

Sales Forecast by Market Segment

Germany, Gastrin Test Volume and Diagnostics

Sales Forecast by Market Segment

Germany, HCG, Test Volume and Diagnostics

Sales Forecast by Market Segment

Germany, Insulin Test Volume and Diagnostics

Sales Forecast by Market Segment

Germany, Interferons Test Volume and

Diagnostics Sales Forecast by Market

Segment

List of Tables (continued)

Germany, Interleukins Test Volume and

Diagnostics Sales Forecast by Market

Segment

Germany, Lymphocyte Subtyping Test Volume and

Diagnostics Sales Forecast by Market

Segment

Germany, NSE Test Volume and Diagnostics

Sales Forecast by Market Segment

Germany, Nucleolar Test Volume and Diagnostics

Sales Forecast by Market Segment

Germany, Occult Blood Test Volume and

Diagnostics Sales Forecast by Market

Segment

Germany, Oncogenes Test Volume and

Diagnostics Sales Forecast by Market

Segment

Germany, Pancreatic Oncofetal Antigen

Test Volume and Diagnostics Sales

Forecast by Market Segment

Germany, Pap Smear Test Volume and

Diagnostics Sales Forecast by Market

Segment

Germany, Parathyroid Hormone Test Volume and

Diagnostics Sales Forecast by Market

Segment

Germany, Progesterone Receptor Test Volume

And Diagnostics Sales Forecast by Market

Segment

List of Tables (continued)

Germany, PAP Test Volume and Diagnostics

Sales Forecast by Market Segment

Germany, PSA Test Volume and Diagnostics

Sales Forecast by Market Segment

Germany, S-100 Protein Test Volume and

Diagnostics Sales Forecast by Market

Segment

Germany, Serotonin Test Volume and

Diagnostics Sales Forecast by Mar

Segment

Germany, Sialic Acid Test Volume and

Diagnostics Sales Forecast by Market

Segment

Germany, Squamous Cell Carcinoma Antigen

Test Volume and Diagnostics Sales Forecast

By Market Segment

Germany, TDT Test Volume and Diagnostics

Sales Forecast by Market Segment

Germany, Thymidine Kinase Test Volume and

Diagnostics Sales Forecast by Market

Segment

Germany, Thyroglobulin Test Volume and

Diagnostics Sales Forecast by Market

Segment

Germany, TPA Test Volume and Diagnostics

Sales Forecast by Market Segment

Germany, Total Tumor Marker Sales

By Major Supplier

List of Tables (continued)

Germany, AFP Testing Market Diagnostics

Sales by Major Supplier

Germany CA 15-3/27.29 Testing Market

Diagnostics Sales by Major Supplier

Germany CA 19-9 Testing Market Diagnostics

Sales by Major Supplier

Germany, CA 125 Testing Market Diagnostics

Sales by Major Supplier

Germany, CEA Testing Market Diagnostics

Sales by Major Supplier

Germany, PSA Testing Market Diagnostics

Sales by Major Supplier

Germany, Tumor Marker Testing

Instrumentation Major Systems

Estimated Placements and Installed Base

By Supplier and Model

Executive Summary Table: Italy, Total Tumor

Marker Test Volume and Diagnostics Sales

Forecast by Market Segment

Italy, Estimated Cancer Death Rates

Per 100,000 Population

Italy, Laboratories Performing Tumor

Marker Tests by Market Segment

Italy, Hospital Laboratories Performing

Tumor Marker Tests by Bed Size

Italy, Commercial/Private Laboratories

Performing Tumor Markers by Annual

Test Volume

List of Tables (continued)

Italy, Total Tumor Marker Test Volume

Forecast by Market Segment

Italy, All Market Segments Major Tumor Marker

Test Volume Forecast

Italy, Hospital Laboratories Major Tumor

Marker Test Volume Forecast

Italy, Commercial/Private Laboratories

Major Tumor Marker Test Volume

Forecast

Italy, Total Tumor Marker Market

Forecast by Market Segment

Italy, All Market Segments Major Tumor

Marker Sales Forecast by Test

Italy, Hospital Laboratories Major

Tumor Marker Forecast by Test

Italy, Commercial/Private Laboratories

Major Tumor Marker Sales Forecast by

Test

Italy, ACTH Test Volume and Diagnostics

Sales Forecast by Market Segment

Italy, AFP Test Volume and Diagnostics

Sales Forecast by Market Segment

Italy, Beta-2 Microglobulin Test Volume

And Diagnostics Sales Forecast by

Market Segment

Italy, CA 15-3/27.29 Test Volume and

Diagnostics Sales Forecast by Market

Segment

List of Tables (continued)

Italy, CA-19-9 Test Volume and Diagnostics

Sales Forecast by Market Segment

Italy, CA 125 Test Volume and Diagnostics

Sales Forecast by Market Segment

Italy, Calcitonin Test Volume and Diagnostics

Sales Forecast by Market Segment

Italy, CEA Test Volume and Diagnostics Sales

Forecast by Market Segment

Italy, Colon Specific Antigen Test Volume

And Diagnostics Sales Forecast by Market

Segment

Italy, Cytokeratins Test Volume and

Diagnostics Sales Forecast by Market

Segment

Italy, Estrogen Receptor Test Volume and

Diagnostics Sales Forecast by Market

Segment

Italy, Ferritin Test Volume and Diagnostics

Sales Forecast by Market Segment

Italy, Gastrin Test Volume and Diagnostics

Sales Forecast by Market Segment

Italy, HCG Test Volume and Diagnostics

Sales Forecast by Market Segment

Italy, Insulin Test Volume and Diagnostics

Sales Forecast by Market Segment

Italy, Lymphocyte Subtyping Test Volume

And Diagnostics Sales Forecast by Market

Segment

List of Tables (continued)

Italy, NSE Test Volume and Diagnostics Sales

Forecast by Market Segment

Italy, Occult Blood Test Volume and Diagnostics

Sales Forecast by Market Segment

Italy, Oncogenes Test Volume and Diagnostics

Sales Forecast by Market Segment

Italy, Pancreatic Oncofetal Antigen Test

Volume and Diagnostics Sales Forecast by

Market Segment

Italy, PAP Smear Test Volume and

Diagnostics Sales Forecast by Market

Segment

Italy, Parathyroid Hormone Test Volume and

Diagnostics Sales Forecast by Market

Segment

Italy, Progesterone Receptor Test Volume and

Diagnostics Sales Forecast by Market

Segment

Italy, PAP Test Volume and Diagnostics Sales

Forecast by Market Segment

Italy, PSA Test Volume and Diagnostics Sales

Forecast by Market Segment

Italy, S-100 Test Volume and Diagnostics

Sales Forecast by Market Segment

Italy, Serotonin Test Volume and

Diagnostics Sales Forecast by Market

Segment

List of Tables (continued)

Italy, Sialic Acid Test Volume and

Diagnostics Sales Forecast by Market

Segment

Italy, Squamous Cell Carcinoma Antigen Test

Volume and Diagnostics Sales Forecast by

Market Segment

Italy, TDT Test Volume and Diagnostics Sales

Forecast by Market Segment

Italy, Thymidine Kinase Test Volume and

Diagnostics Sales Forecast by Market

Segment

Italy, Thyroglobulin Test Volume and

Diagnostics Sales Forecast by Market

Segment

Italy, TPA Test Volume and Diagnostics Sales

Forecast by Market Segment

Italy, Total Tumor Markers

Sales by Major Supplier

Italy, AFP Testing Market Diagnostics

Sales by Major Supplier

Italy, CEA Testing Market Diagnostics

Sales by Major Supplier

Italy, PSA Testing Market Diagnostics

Sales by Major Supplier

Italy, Tumor Marker Testing Instrumentation

Major Non-Isotopic Systems Estimated

Installed Base by Supplier and Model

List of Tables (continued)

Executive Summary Table: Japan, Total Tumor

Marker Test Volume and Sales Forecast by

Market Segment

Japan, Estimated Cancer Death Rates

Per 100,000 Population

Japan, Laboratories Performing Tumor

Marker Tests by Market Segment

Japan, Hospital Laboratories Performing

Tumor Marker Tests by Bed Size

Commercial/Private Laboratories

Performing Tumor Marker Tests

By Annual Volume

Japan, Total Tumor Marker Test Volume

Forecast by Market Segment

Japan, All Market Segments Major Tumor

Marker Test Volume Forecast

Japan, Hospital Laboratories Major Tumor

Marker Test Volume Forecast by Assay

Japan, Commercial/Private Laboratories Major

Tumor Marker Test Volume Forecast

Japan, Total Tumor Marker Sales

Forecast by Market Segment

Japan, All Market Segments Major Tumor

Marker Sales Forecast by Test

Japan, Hospital Laboratories Major Tumor

Marker Sales Forecast by Test

Japan, Commercial/Private Laboratories Major

Tumor Marker Sales Forecast by Test

List of Tables (continued)

Japan, ACTH Test Volume and Diagnostics Sales

Forecast by Market Segment

Japan, AFP Test Volume and Diagnostics Sales

Forecast by Market Segment

Japan, Beta-2 Microglobulin Test Volume and

Diagnostics Sales Forecast by Market

Segment

Japan, CA 15-3/27.29 Test Volume and

Diagnostics Sales Forecast by Market

Segment

Japan, CA 19-9 Test Volume and Diagnostics

Sales Forecast by Market Segment

Japan, CA-125 Test Volume and Diagnostics

Sales Forecast by Market Segment

Japan, Calcitonin Test Volume and Diagnostics

Sales Forecast by Market Segment

Japan, Cathepsin Test Volume and Diagnostics

Sales Forecast by Market Segment

Japan, CEA Test Volume and Diagnostics

Sales Forecast by Market Segment

Japan, Chromogranin Test Volume and

Diagnostics Sales Forecast by Market

Segment

Japan, Colon-Specific Antigen Test Volume

And Diagnostics Sales Forecast by Market

Segment

List of Tables (continued)

Japan, Cytokeratins Test Volume and

Diagnostics Sales Forecast by Market

Segment

Japan, Estrogen Receptor Test Volume and

Diagnostics Sales Forecast by Market

Segment

Japan, Ferritin Test Volume and

Diagnostics Sales Forecast by Market

Segment

Japan, Gastrin Test Volume and

Diagnostics Sales Forecast by Market

Segment

Japan, HCG Test Volume and Diagnostics Sales

Forecast by Market Segment

Japan, Insulin Test Volume and Diagnostics

Sales Forecast by Market Segment

Japan, Interferons Test Volume and

Diagnostics Sales Forecast by Market

Segment

Japan, Interleukins Test Volume and

Diagnostics Sales Forecast by Market

Segment

Japan, Lymphocyte Subtyping Test Volume and

Diagnostics Sales Forecast by Market

Segment

Japan, NSE Test Volume and Diagnostics Sales

Forecast by Market Segment

Japan, Nucleolar Test Volume and

Diagnostics Sales Forecast by Market

Segment

List of Tables (continued)

Japan, Occult Blood Test Volume and

Diagnostics Sales Forecast by Market

Segment

Japan, Oncogenes Test Volume and

Diagnostics Sales Forecast by Market

Segment

Japan, Pancreatic Oncofetal Antigen

Test Volume and Diagnostics

Sales Forecast by Market Segment

Japan, PAP Smear Test Volume and

Diagnostics Sales Forecast by Market

Segment

Japan, Parathyroid Hormone

Test Volume and Diagnostics

Sales Forecast by Market Segment

Japan, Progesterone Receptor

Test Volume and Diagnostics

Sales Forecast by Market Segment

Japan, PAP Test Volume and Diagnostics Sales

Forecast by Market Segment

Japan, PSA Test Volume and Diagnostics Sales

Forecast by Market Segment

Japan, S-100 Protein Test Volume and

Diagnostics Sales Forecast by Market

Segment

Japan, Serotonin Test Volume and

Diagnostics Sales Forecast by Market

Segment

List of Tables (continued)

Japan, Sialic Acid Test Volume and

Diagnostics Sales Forecast by Market

Segment

Japan, Squamous Cell Carcinoma Antigen

Test Volume and Diagnostics Sales

Forecast by Market Segment

Japan, TDT Test Volume and Diagnostics

Sales Forecast by Market Segment

Japan, Thymidine Kinase

Test Volume and Diagnostics

Sales Forecast by Market Segment

Japan, Thyroglobulin

Test Volume and Diagnostics

Sales Forecast by Market Segment

Japan, TPA, Test Volume and Diagnostics

Sales Forecast by Market Segment

Japan, Total Tumor Marker

Sales by Major Supplier

Japan, AFP Testing Market Diagnostics

Sales by Major Supplier

Japan, CA 15-3/27.29 Testing Market

Diagnostics Sales by Major Supplier

Japan, CA 19-9 Testing Market Diagnostics

Sales by Major Supplier

Japan, CA 125 Testing Market Diagnostics

Sales by Major Supplier

Japan, Calcitonin Testing Market Diagnostics

Sales by Major Supplier

List of Tables (continued)

Japan, CEA Testing Market Diagnostics

Sales by Major Supplier

Japan, NSE Testing Market Diagnostics

Sales by Major Supplier

Japan, PAP Testing Market Diagnostics

Sales by Major Supplier

Japan, PSA Testing Market Diagnostics

Sales by Major Supplier

Japan, Tumor Marker Testing

Instrumentation, Major System

Estimated Placements and Installed Base

By Supplier and Model

Executive Summary Table: Spain, Total

Tumor Marker Test Volume and Sales

Forecast by Market Segment

Spain, Estimated Cancer Death Rates

Per 100,000 Population

Spain, Laboratories Performing Tumor

Marker Tests by Market Segment

Spain, Hospital Laboratories Performing

Tumor Marker Tests by Bed Size

Spain, Commercial/Private Laboratories

Performing Tumor Markers by

Annual Test Volume

Spain, Total Tumor Marker Test Volume

Forecast by Market Segment

Spain, All Market Segment Major Cancer

Diagnostic Test Volume Forecast

List of Tables (continued)

Spain, Hospital Laboratories Major Cancer

Diagnostic Test Volume Forecast by

Test

Spain, Commercial/Private Laboratories

Major Tumor Marker Test Volume Forecast

Spain,

To order this report:

In Vitro Diagnostic Industry: Tumor Markers: US, Europe, Japan--Emerging Opportunities and Business Expansion Strategies for Suppliers

In Vitro Diagnostic Business News

More  Market Research Report

Check our  Company Profile, SWOT and Revenue Analysis!

Nicolas Bombourg
Reportlinker
Email: [email protected]
US: (805)652-2626
Intl: +1 805-652-2626

SOURCE Reportlinker